Anyone who has compared a fish oil capsule to a fish oil tablet has likely noticed the difference is not just cosmetic. Softgels remain the dominant delivery format for fat-soluble nutrients like vitamin D, vitamin E, omega-3 fatty acids, and CoQ10, and this preference is rooted in genuine chemistry rather than manufacturing convenience or tradition alone.

Fat-soluble nutrients need to be dissolved in an oil or fat-based medium before the body can properly absorb them. Softgels are essentially a liquid or semi-liquid fill encased in a gelatin or plant-based shell, which means the active ingredient is already suspended in an oil base at the point of manufacturing, ready for absorption as soon as the shell dissolves in the digestive tract. Tablets, by comparison, require the fat-soluble ingredient to be either incorporated into a dry powder form through additional processing steps or absorbed alongside dietary fat consumed separately, both of which introduce additional variables that can affect actual bioavailability.

This distinction becomes especially important for ingredients like CoQ10, which has notoriously poor bioavailability in dry powder form due to its large molecular structure and poor water solubility. Softgel formulations, particularly those using specialized carrier oils or emulsification techniques, have been shown to significantly improve absorption compared to standard tablet formats. This is part of why softgel capsule manufacturing remains a specialized capability that not every facility can offer at a consistent quality level, since achieving genuine bioavailability improvements requires more than simply filling a capsule with oil.

Stability is another factor favoring softgels for certain nutrients. Vitamin E and omega-3 fatty acids are both prone to oxidation when exposed to air, and the sealed nature of a softgel shell provides better protection against oxygen exposure compared to a compressed tablet, which has more surface area exposed during storage and handling. This translates into better shelf life retention for sensitive ingredients, meaning a softgel formulation is more likely to deliver its labeled potency at the point of consumption compared to a tablet that has been sitting on a shelf for several months.

Manufacturing softgels does come with its own set of challenges that make it a more specialized process than standard tablet production. The shell formulation needs to be precisely calibrated for thickness and composition to ensure it dissolves at the right rate in the digestive tract, neither too quickly, which can affect absorption timing, nor too slowly, which risks the capsule passing through the body before fully dissolving. Fill material also needs to be carefully formulated to avoid leakage or shell interaction issues over the product’s shelf life, something that becomes more complex when multiple active ingredients are combined in a single softgel formulation.

Consumer preference also plays a role that is easy to underestimate. Softgels are generally perceived as easier to swallow due to their smooth, rounded shape compared to some tablet formulations, and they typically carry less of an unpleasant aftertaste since the shell masks the flavor of the fill material until it is well into the digestive process. This perception, combined with the genuine bioavailability advantages for fat-soluble ingredients, keeps consumer demand for softgel formats strong across multiple supplement categories, even as sachets and gummies have grown in popularity for other product types.

As broader nutraceutical manufacturing trends 2026 continue emphasizing bioavailability and ingredient efficacy as key differentiators rather than just ingredient lists alone, softgels are likely to remain the preferred format specifically for fat-soluble nutrients, precisely because the science supporting this preference has not meaningfully changed, even as other parts of the industry continue to innovate around newer delivery formats.